Investigation of In-Vitro Cytotoxic and Potential Anticancer Activities of Flavonoidal Aglycones from Egyptian Propolis | ||
| Records of Pharmaceutical and Biomedical Sciences | ||
| Article 3, Volume 1, Issue 2, September 2017, Pages 13-20 PDF (860.7 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/rpbs.2018.5924 | ||
| Authors | ||
| Reham Ibrahim* 1; Ahmed Seif El-Din2; Marwa Abu-Serie3; Nevine Abd El Rahman4; Maha El-Demellawy3, 5; Aly Metwally2 | ||
| 1Department of Pharmacognosy, Faculty of Pharmacy, University of Alexandria, Alexandria 21521, Egypt | ||
| 2Department of Pharmacognosy, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt | ||
| 3Medical Biotechnolog Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt | ||
| 4Pharmaceutical & Fermentation Industries Development Center, City of Scientifc Research and Technological Applications, Alexandria, Egypt | ||
| 5Pharmaceutical & Fermentation Industries Development Center, City of Scientific Research and Technological Applications, Alexandria, Egypt | ||
| Abstract | ||
| The in-vitro anticancer activity of Egyptian propolis ethanol extract as well as two isolated flavonoidal aglycones, tectochrysin and quercetin-3,3’-di-O-methylether,was assayed using neutral red uptake method on human breast cancer (MCF-7) and colorectal adenocarcinoma (Caco-2) cell lines, in addition to their in-vitro cytotoxic effect to normal human peripheral blood mononuclear cells (PBMCs). Egyptian propolis ethanol extract and quercetin-3,3’-di-O-methylether showed both high activity and selectivity towards the two tested cell lines suggesting them as effective, safe and selective anticancer candidates against both breast and colorectal cancer. | ||
| Keywords | ||
| Propolis; Flavonoidal aglycones; In-vitro anticancer activity | ||
|
Statistics Article View: 521 PDF Download: 599 |
||